These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 28727801)

  • 1. Proponent or collaborative: Physician perspectives and approaches to disease modifying therapies in sickle cell disease.
    Bakshi N; Sinha CB; Ross D; Khemani K; Loewenstein G; Krishnamurti L
    PLoS One; 2017; 12(7):e0178413. PubMed ID: 28727801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Patient-Physician Communication on the Use of Hydroxyurea in Adult Patients with Sickle Cell Disease.
    Jabour SM; Beachy S; Coburn S; Lanzkron S; Eakin MN
    J Racial Ethn Health Disparities; 2019 Dec; 6(6):1233-1243. PubMed ID: 31410784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxyurea therapy for children with sickle cell disease: describing how caregivers make this decision.
    Creary S; Zickmund S; Ross D; Krishnamurti L; Bogen DL
    BMC Res Notes; 2015 Aug; 8():372. PubMed ID: 26303306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New therapies and approaches to transfusion in sickle cell disease in children.
    Styles LA; Vichinsky EP
    Curr Opin Pediatr; 1997 Feb; 9(1):41-5. PubMed ID: 9088754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shared decision making for hydroxyurea treatment initiation in children with sickle cell anemia.
    Crosby LE; Shook LM; Ware RE; Brinkman WB
    Pediatr Blood Cancer; 2015 Feb; 62(2):184-185. PubMed ID: 25308571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Practice Patterns in Sickle Cell Disease Treatment: Disease-modifying and Potentially Curative Therapies.
    Sánchez LM; Morrone K; Frei-Jones M; Fasipe TA
    J Pediatr Hematol Oncol; 2024 Jul; 46(5):e277-e283. PubMed ID: 38718300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and evaluation of a patient empowerment video to promote hydroxyurea adoption in sickle cell disease.
    LaVista JM; Treise DM; Dunbar LN; Ritho J; Hartzema AG; Lottenberg R
    J Natl Med Assoc; 2009 Mar; 101(3):251-7. PubMed ID: 19331257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Patient and Caregiver Attitudes and Approaches to Decision-Making Regarding Bone Marrow Transplant for Sickle Cell Disease: A Qualitative Study.
    Bakshi N; Katoch D; Sinha CB; Ross D; Quarmyne MO; Loewenstein G; Krishnamurti L
    JAMA Netw Open; 2020 May; 3(5):e206742. PubMed ID: 32469414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Provider barriers to hydroxyurea use in adults with sickle cell disease: a survey of the Sickle Cell Disease Adult Provider Network.
    Lanzkron S; Haywood C; Hassell KL; Rand C
    J Natl Med Assoc; 2008 Aug; 100(8):968-73. PubMed ID: 18717150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric Hematologists Report Infrequent Prognosis Discussions in the Routine Care of Children with Sickle Cell Disease.
    Pecker LH; Silver EJ; Roth M; Manwani D
    J Health Care Poor Underserved; 2020; 31(1):398-423. PubMed ID: 32037339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease-modifying therapies for sickle cell disease: Decisional needs and supports among adolescents and young adults.
    Ding K; Bear B; Sood E; Alderfer M; Crosby L; Hildenbrand AK
    Pediatr Blood Cancer; 2024 Jul; 71(7):e30999. PubMed ID: 38622789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding patient-related barriers to hydroxyurea use among adolescent and adult patients with sickle cell disease in Mulago and Kiruddu hospitals, Uganda, a qualitative study.
    Namaganda P; Nantume P; Mubiru KR; Twimukye A; Wiltshire CS
    BMC Health Serv Res; 2024 May; 24(1):666. PubMed ID: 38802815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Effectiveness of a Web-Based Patient Decision Aid for Therapeutic Options for Sickle Cell Disease: Randomized Controlled Trial.
    Krishnamurti L; Ross D; Sinha C; Leong T; Bakshi N; Mittal N; Veludhandi D; Pham AP; Taneja A; Gupta K; Nwanze J; Matthews AM; Joshi S; Vazquez Olivieri V; Arjunan S; Okonkwo I; Lukombo I; Lane P; Bakshi N; Loewenstein G
    J Med Internet Res; 2019 Dec; 21(12):e14462. PubMed ID: 31799940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of sickle cell disease.
    Steinberg MH
    N Engl J Med; 1999 Apr; 340(13):1021-30. PubMed ID: 10099145
    [No Abstract]   [Full Text] [Related]  

  • 15. From trust to skepticism: An in-depth analysis across age groups of adults with sickle cell disease on their perspectives regarding hydroxyurea.
    Sinha CB; Bakshi N; Ross D; Krishnamurti L
    PLoS One; 2018; 13(6):e0199375. PubMed ID: 29949647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment Options for Sickle Cell Disease.
    Meier ER
    Pediatr Clin North Am; 2018 Jun; 65(3):427-443. PubMed ID: 29803275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxyurea therapy for sickle cell disease in community-based practices: a survey of Florida and North Carolina hematologists/oncologists.
    Zumberg MS; Reddy S; Boyette RL; Schwartz RJ; Konrad TR; Lottenberg R
    Am J Hematol; 2005 Jun; 79(2):107-13. PubMed ID: 15929107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxyurea: Clinical and Hematological Effects in Patients With Sickle Cell Anemia.
    Keikhaei B; Yousefi H; Bahadoram M
    Glob J Health Sci; 2015 Aug; 8(3):252-6. PubMed ID: 26493428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel approaches to the treatment of sickle cell disease: the potential of histone deacetylase inhibitors.
    Okam MM; Ebert BL
    Expert Rev Hematol; 2012 Jun; 5(3):303-11. PubMed ID: 22780210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.
    Yawn BP; Buchanan GR; Afenyi-Annan AN; Ballas SK; Hassell KL; James AH; Jordan L; Lanzkron SM; Lottenberg R; Savage WJ; Tanabe PJ; Ware RE; Murad MH; Goldsmith JC; Ortiz E; Fulwood R; Horton A; John-Sowah J
    JAMA; 2014 Sep; 312(10):1033-48. PubMed ID: 25203083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.